Literature DB >> 4143918

Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.

B Lemmer, G Wiethold, D Hellenbrecht, I J Bak, H Grobecker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4143918     DOI： 10.1007/bf00500058

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  16 in total

1.  The preparation and chemical characteristics of hemoglobin-free ghosts of human erythrocytes.

Authors:  J T DODGE; C MITCHELL; D J HANAHAN
Journal:  Arch Biochem Biophys       Date:  1963-01       Impact factor: 4.013

2.  Membrane surface specialization of blood platelet and megakaryocyte.

Authors:  K Nakao; A A Angrist
Journal:  Nature       Date:  1968-03-09       Impact factor: 49.962

Review 3.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

4.  The human platelet as a pharmacologic model for the adrenergic neuron. The uptake and release of norepinephrine.

Authors:  W B Abrams; H M Solomon
Journal:  Clin Pharmacol Ther       Date:  1969 Sep-Oct       Impact factor: 6.875

5.  [Release of serotonin and histamine from thrombocytes by aliphatic and aromatic amines].

Authors:  B May; I Menkens; E Westermann
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1969

Review 6.  Perspectives in adrenergic beta-receptor blockade.

Authors:  J D Fitzgerald
Journal:  Clin Pharmacol Ther       Date:  1969 May-Jun       Impact factor: 6.875

Review 7.  Membrane stabilization by drugs: tranquilizers, steroids, and anesthetics.

Authors:  P M Seeman
Journal:  Int Rev Neurobiol       Date:  1966       Impact factor: 3.230

8.  Accumulation of quinidine by human blood platelets: effects on platelet ultrastructure and 5-hydroxytryptamine.

Authors:  D J Boullin; R A O'Brien
Journal:  Br J Pharmacol       Date:  1971-05       Impact factor: 8.739

9.  Uptake, metabolism and release of (3H)-adrenaline by human platelets.

Authors:  G V Born; J B Smith
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

10.  The uptake of adrenaline and noradrenaline by blood platelets of the pig.

Authors:  G V BORN; O HORNYKIEWICZ; A STAFFORD
Journal:  Br J Pharmacol Chemother       Date:  1958-12
View more
  9 in total

1.  The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.

Authors:  B Lemmer; R Saller
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

2.  Cardioprotection by oxyfedrine in hereditary cardiomyopathic hamsters.

Authors:  K Lossnitzer; A Konrad; W Mohr; M Jakob; F Stroman
Journal:  Basic Res Cardiol       Date:  1979 Nov-Dec       Impact factor: 17.165

Review 3.  Platelets, thrombosis and drugs.

Authors:  J F Mustard; M A Packham
Journal:  Drugs       Date:  1975       Impact factor: 9.546

4.  The effect of beta-adrenergic blocking drugs and inhibitors of phosphodiestease on histamine release from isolated mast cells.

Authors:  R Nosál; Z Menyhardtová
Journal:  Agents Actions       Date:  1977-07

5.  Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.

Authors:  D Hellenbrecht; B Lemmer; G Wiethold; H Grobecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

6.  The inhibition by beta-adrenoceptor blocking agents of calcium uptake into and efflux from isolated sarcoplasmic vesicles.

Authors:  D M Temple; W Hasselbach; M Makinose
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

7.  The effect of Trimepranol on thrombocyte function and histamin release in the rat.

Authors:  R Nosal; Z Menyhardtová
Journal:  Agents Actions       Date:  1975-02

8.  Quantitative correlation between histamine and 35S release from isolated rat mast cells due to the beta-adrenergic blocking drug Kö 1124.

Authors:  R Nosál; J Pecivová; K Drábiková
Journal:  Agents Actions       Date:  1981-07

9.  Characteristics of (+/-)-[14C]-oxprenolol and (+/-)-[14C]-propranolol incorporation by rat lung slices.

Authors:  B A Hemsworth; J A Street
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.